Corvus Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.83
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.16
|
-0.32
|
-0.16
|
-100.00%
|
|
2022-06-30
|
-0.18
|
-0.18
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.15
|
-0.18
|
-0.03
|
-20.00%
|
|
2021-12-31
|
-0.19
|
-0.20
|
-0.01
|
-5.26%
|
|
2021-09-30
|
-0.26
|
-0.24
|
0.02
|
7.69%
|
|
2021-06-30
|
-0.32
|
-0.28
|
0.04
|
12.50%
|
|
2021-03-31
|
-0.31
|
-0.34
|
-0.03
|
-9.68%
|
|
2020-12-31
|
-0.32
|
0.92
|
1.24
|
387.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.68
|
|
2021-12-31
|
-1.06
|
|
2020-12-31
|
-0.21
|
|
2019-12-31
|
-1.59
|
|
2018-12-31
|
-1.75
|
|
2017-12-31
|
-2.72
|
|
2016-12-31
|
-6.88
|